Savio E - Search Results

1

188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates.

Savio E, Ures MC, Zeledón P, Trindade V, Paolino A, Mockford V, Malanga A, Fernández M, Gaudiano J. Savio E, et al. BMC Nucl Med. 2004 Jan 30;4(1):1. doi: 10.1186/1471-2385-4-1. BMC Nucl Med. 2004. PMID: 15040807 Free PMC article.

2

Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose.

Savio E, Gaudiano J, Robles AM, Balter H, Paolino A, López A, Hermida JC, De Marco E, Martinez G, Osinaga E, Knapp FF Jr. Savio E, et al. BMC Nucl Med. 2001;1(1):2. doi: 10.1186/1471-2385-1-2. BMC Nucl Med. 2001. PMID: 11734069 Free PMC article.

3

Physico-chemical characterisation and biological evaluation of 188-Rhenium colloids for radiosynovectomy.

Ures M, Savio E, Malanga A, Fernández M, Paolino A, Gaudiano J. Ures M, et al. Among authors: savio e. BMC Nucl Med. 2002 Oct 14;2(1):1. doi: 10.1186/1471-2385-2-1. BMC Nucl Med. 2002. PMID: 12379158 Free PMC article.

4

Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studies.

Terán M, Savio E, Paolino A, Frier M. Terán M, et al. Among authors: savio e. BMC Nucl Med. 2005 Oct 18;5:5. doi: 10.1186/1471-2385-5-5. BMC Nucl Med. 2005. PMID: 16232323 Free PMC article.

5

Biological studies in animal models using [99mTc](CO)3 recombinant annexin V as diagnostic agent of apoptotic processes.

Terán MA, Martínez E, Reyes AL, Paolino A, Vital M, Esperón P, Pacheco JP, Savio E. Terán MA, et al. Among authors: savio e. Nucl Med Biol. 2011 Feb;38(2):279-85. doi: 10.1016/j.nucmedbio.2010.08.007. Epub 2010 Nov 5. Nucl Med Biol. 2011. PMID: 21315284

6

Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECD.

Terán M, Savio E, Paolino A, Frier M. Terán M, et al. Among authors: savio e. Eur J Pharm Biopharm. 2004 Mar;57(2):347-52. doi: 10.1016/j.ejpb.2003.11.003. Eur J Pharm Biopharm. 2004. PMID: 15018995

7

Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?

Domínguez L, Savio E, Saldaña J, Malanga A, Quevedo D, Camarote C, Ochoa A, Fagiolino P. Domínguez L, et al. Among authors: savio e. Boll Chim Farm. 1998 Nov;137(10):383-6. Boll Chim Farm. 1998. PMID: 9880943 Clinical Trial.

8

Lipidic matrix of albendazole: an alternative for systemic infections.

Savio E, Domínguez L, Malanga A, Quevedo D, Saldaña J, Camarote C, Ochoa A, Fagiolino P. Savio E, et al. Boll Chim Farm. 1998 Oct;137(9):345-9. Boll Chim Farm. 1998. PMID: 9859596 Clinical Trial.

9

Biological Assessment of a ¹⁸F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer's Disease as a Potential Astrocytosis Marker.

Kreimerman I, Reyes AL, Paolino A, Pardo T, Porcal W, Ibarra M, Oliver P, Savio E, Engler H. Kreimerman I, et al. Among authors: savio e. Front Neurosci. 2019 Jul 16;13:734. doi: 10.3389/fnins.2019.00734. eCollection 2019. Front Neurosci. 2019. PMID: 31379487 Free PMC article.

10

Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model.

Gambini JP, Cabral P, Alonso O, Savio E, Figueroa SD, Zhang X, Ma L, Deutscher SL, Quinn TP. Gambini JP, et al. Among authors: savio e. Nucl Med Biol. 2011 Feb;38(2):255-60. doi: 10.1016/j.nucmedbio.2010.08.002. Epub 2010 Oct 27. Nucl Med Biol. 2011. PMID: 21315281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters